BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9219848)

  • 1. Stromal fibroblasts influence oral squamous-cell carcinoma cell interactions with tenascin-C.
    Ramos DM; Chen BL; Boylen K; Stern M; Kramer RH; Sheppard D; Nishimura SL; Greenspan D; Zardi L; Pytela R
    Int J Cancer; 1997 Jul; 72(2):369-76. PubMed ID: 9219848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tenascin-C matrix assembly in oral squamous cell carcinoma.
    Ramos DM; Chen B; Regezi J; Zardi L; Pytela R
    Int J Cancer; 1998 Mar; 75(5):680-7. PubMed ID: 9495234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the alpha(v)beta6 integrin in human oral squamous cell carcinoma growth in vivo and in vitro.
    Xue H; Atakilit A; Zhu W; Li X; Ramos DM; Pytela R
    Biochem Biophys Res Commun; 2001 Nov; 288(3):610-8. PubMed ID: 11676487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble fibronectin promotes migration of oral squamous-cell carcinoma cells.
    Liu H; Chen B; Zardi L; Ramos DM
    Int J Cancer; 1998 Oct; 78(2):261-7. PubMed ID: 9754661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of TGF-beta1 latency-associated peptide (LAP) to alpha(v)beta6 integrin modulates behaviour of squamous carcinoma cells.
    Thomas GJ; Hart IR; Speight PM; Marshall JF
    Br J Cancer; 2002 Oct; 87(8):859-67. PubMed ID: 12373600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of integrin alpha9 subunit and tenascin in oral leukoplakia, lichen planus, and squamous cell carcinoma.
    Häkkinen L; Kainulainen T; Salo T; Grenman R; Larjava H
    Oral Dis; 1999 Jul; 5(3):210-7. PubMed ID: 10483066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of emmprin by oral squamous cell carcinoma.
    Bordador LC; Li X; Toole B; Chen B; Regezi J; Zardi L; Hu Y; Ramos DM
    Int J Cancer; 2000 Feb; 85(3):347-52. PubMed ID: 10652425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of integrin beta 6 enhances invasive behavior in oral squamous cell carcinoma.
    Ramos DM; But M; Regezi J; Schmidt BL; Atakilit A; Dang D; Ellis D; Jordan R; Li X
    Matrix Biol; 2002 Apr; 21(3):297-307. PubMed ID: 12009335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrillary co-deposition of laminin-5 and large unspliced tenascin-C in the invasive front of oral squamous cell carcinoma in vivo and in vitro.
    Berndt A; Borsi L; Hyckel P; Kosmehl H
    J Cancer Res Clin Oncol; 2001 May; 127(5):286-92. PubMed ID: 11355143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the integrin alpha v beta6 in regulating the epithelial to mesenchymal transition in oral cancer.
    Ramos DM; Dang D; Sadler S
    Anticancer Res; 2009 Jan; 29(1):125-30. PubMed ID: 19331141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of alpha(v)beta6 integrin in oral leukoplakia.
    Hamidi S; Salo T; Kainulainen T; Epstein J; Lerner K; Larjava H
    Br J Cancer; 2000 Apr; 82(8):1433-40. PubMed ID: 10780523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parenchymal-stromal switching for extracellular matrix production on invasion of oral squamous cell carcinoma.
    Metwaly H; Maruyama S; Yamazaki M; Tsuneki M; Abé T; Jen KY; Cheng J; Saku T
    Hum Pathol; 2012 Nov; 43(11):1973-81. PubMed ID: 22575259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irradiated fibroblast-induced bystander effects on invasive growth of squamous cell carcinoma under cancer-stromal cell interaction.
    Kamochi N; Nakashima M; Aoki S; Uchihashi K; Sugihara H; Toda S; Kudo S
    Cancer Sci; 2008 Dec; 99(12):2417-27. PubMed ID: 19018771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of tenascin in oral premalignant lesions and squamous cell carcinoma.
    Tiitta O; Happonen RP; Virtanen I; Luomanen M
    J Oral Pathol Med; 1994 Nov; 23(10):446-50. PubMed ID: 7532219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation and function of the extracellular matrix protein tenascin-C in ovarian cancer cell lines.
    Wilson KE; Bartlett JM; Miller EP; Smyth JF; Mullen P; Miller WR; Langdon SP
    Br J Cancer; 1999 May; 80(5-6):685-92. PubMed ID: 10360644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tenascin-C expression and its prognostic significance in oral and pharyngeal squamous cell carcinoma.
    Atula T; Hedström J; Finne P; Leivo I; Markkanen-Leppänen M; Haglund C
    Anticancer Res; 2003; 23(3C):3051-6. PubMed ID: 12926160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases and TGFbeta1 modulate oral tumor cell matrix.
    Dang D; Yang Y; Li X; Atakilit A; Regezi J; Eisele D; Ellis D; Ramos DM
    Biochem Biophys Res Commun; 2004 Apr; 316(3):937-42. PubMed ID: 15033492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of {alpha}v{beta}6-positive stem cells in oral squamous cell carcinoma.
    Dang D; Ramos DM
    Anticancer Res; 2009 Jun; 29(6):2043-9. PubMed ID: 19528463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour-associated macrophages are recruited and differentiated in the neoplastic stroma of oral squamous cell carcinoma.
    Essa AA; Yamazaki M; Maruyama S; Abé T; Babkair H; Raghib AM; Megahed EM; Cheng J; Saku T
    Pathology; 2016 Apr; 48(3):219-27. PubMed ID: 27020496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EMMPRIN modulates migration and deposition of TN-C in oral squamous carcinoma.
    Dang D; Atakilit A; Ramos DM
    Anticancer Res; 2008; 28(4B):2049-54. PubMed ID: 18751374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.